Saitama Medical School, Moroyama
Fetal heterotaxy syndrome is associated with broad spectrum of cardiac pathology
Published in Health Business Week, May 12th, 2006
According to a recent analysis from Japan, "Because there is a paucity of information regarding the diagnosis and outcomes of fetal heterotaxy syndrome (HS), this study sought to determine the spectrum of cardiac pathology, accuracy of diagnosis, and outcome of fetal HS."
"All cases of fetal HS encountered in the investigators' institution over a 10-year period through 2002 were identified," wrote M. Taketazu and colleagues at University of Saitama in Moroyama. "Prenatal and postnatal echocardiograms and medical records were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-05-12)
More Articles from Health Business Week
- AMDL, Inc.
AMDL closes private offering of shares and warrants - Acacia Research Corporation
CombiMatrix and Texas A&M University receive grant, focus is DNA hybridization on microarrays - Acusphere, Inc.
Acusphere prices common stock and warrant offering - Affitech AS
Affitech raises NOK 86 million in private placement - Alnylam Pharmaceuticals, Inc.
Alnylam to collaborate with U.S. Army on RNAi therapeutics for biodefense threats - AngioScore, Inc.
AngioScore completes $30M financing to fund U.S. product launch - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
